Login / Signup

Submucosal Epstein-Barr Virus Positive Polymorphic B-cell Lymphoproliferative Disorder of the Larynx: A Case Report.

Sehreen MumtazEstephania CandeloMurli KrishnaLiuyan JiangAlok A BhattMargaret BridgesAndrés Felipe Cardona-CardonaAmy L RuttFlorentina BerianuRonald R Butendieck
Published in: Ear, nose, & throat journal (2024)
Epstein-Barr virus (EBV) belongs to the group of human herpes virus and can cause clinical and subclinical infections. Although EBV-related disease presentations are similar, they can lead to oncogenic transformation with various clinical manifestations. A thorough workup with morphology, immunohistochemistry, and molecular studies is crucial for the diagnosis of EBV-positive polymorphic B-cell lymphoproliferative disorder, not otherwise specified (NOS), which is a new entity introduced by International Consensus Classification in 2022. We describe an interesting presentation of EBV-positive polymorphic B-cell lymphoproliferative disorder with laryngeal involvement to bring awareness to this entity and we would like to address the need for more accessible treatment options.
Keyphrases
  • epstein barr virus
  • diffuse large b cell lymphoma
  • endothelial cells
  • machine learning
  • deep learning
  • transcription factor
  • case report
  • nitric oxide